Safety and Efficacy of Allogeneic Bone Marrow MSCs in Ankylosing Spondylitis

NCT07632599 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

BIOLOGICAL: IV administration of CG-BM1
BIOLOGICAL: Placebo
BIOLOGICAL: CG-BM1

Sponsor

Eighth Affiliated Hospital, Sun Yat-sen University

Collaborators

[object Object]